Julie Brahmer, MD, discusses the unique features of the phase 3 CheckMate 9LA trial in patients with metastatic non–small cell lung cancer.

Researchers have identified a new biomarker in multiple sclerosis (MS): the thickness of the inflammatory rim surrounding ...

Until prospective data are available, researchers recommend that patients with ER-low breast cancer “should be counseled regarding the potential benefit” of adjuvant endocrine therapy.

Analysis of single bone may tell us if the platypus is an evolutionary anomaly — starting on land, then returning to water.

Following results from their new retrospective study, the researchers suggested that immediate reconstruction of the nose ...

A small bone found 30 years ago at Dinosaur Cove in southeastern Australia could turn what we know about the evolution of echidnas and platypuses on its head.

Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival ...

Most skin cancers are treatable, mainly if they're found early. Regular skin checks are an important part of your health ...

Immunic's lead asset, vidofludimus calcium, shows promise in MS trials, with positive interim results. See why I rate IMUX ...

Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing efimosfermin alfa, a once-monthly FGF21 analogue for the treatment of metabolic dysfunction-associated steatohepatitis ...

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...